Blueprint Medicines is a premier global biopharmaceutical company dedicated to addressing the most challenging diseases through a research-driven, patient-centric lens. By focusing on oncology, hematology, and innovative therapeutic modalities, the company targets the root causes of disease to create life-changing impact.
As a Sanofi company, Blueprint Medicines benefits from global reach while maintaining its agile, innovative spirit. Through its signature 'Blueflex' operating model, the company fosters a dynamic, high-performance culture that balances in-office collaboration with the flexibility needed for modern productivity, attracting top scientific talent committed to scientific excellence and patient advocacy.